Glycemic Control in Type 2 Diabetes Mellitus: Initial TreatmentCARLOS R. HAMILTON, JR., MD, FACE President of the American College of Endocrinology
Professor of Internal medicine University of Texas Houston Medical School Carlos R. Hamilton, Jr., MD, FACE, has practiced clinical endocrinology and internal medicine, and he is the executive vice president of the University of Texas Health Science Center at Houston and a professor of internal medicine at the UT Houston Medical School. After graduating from Baylor College of Medicine, he completed his internship and residency at the Johns Hopkins Hospital, an endocrine fellowship at the Massachusetts General Hospital, and was chief resident in medicine at Hopkins. He was on the full-time faculty at Hopkins before serving two years as an endocrinologist at the Wilford Hall USAF Medical Center in San Antonio. He was in private practice for 26 years and was a clinical professor of medicine at Baylor College of Medicine before assuming his present position. Dr. Hamilton has been active in medical organizations primarily as an advocate for medical practice and patient’s rights. He has been a member of the AACE board of directors and served as chair of the AACE legislative and regulatory committee. He has also served as president of the Texas Society of Internal Medicine, the Harris County Medical Society and as chair of the Texas Medical Association Political Action Committee. He has served as a trustee of the American Society of Internal Medicine, as a member of the ACP-ASIM Health and Public Policy Committee and as a member of the AMA Federation Advisory Committee. He served as the 2004–2005 AACE president and as a trustee of the American College of Endocrinology. He is a past president on the AACE board of directors and president-elect of the American College of Endocrinology. He is a member of the practicing physicians advisory council to the US Secretary of Health and Human Services for issues related to the Center of Medicare and Medicaid Services. He also serves on the health, medicine and research committee of the World Anti-Doping Agency, which oversees the international prohibitions of the use of hormones and performance enhancing substances in athletic competition.
Professor of Medicine
Baylor College of Medicine. Dr. Alan Garber graduated from Temple University, Philadelphia, in 1968, completed a PhD in Biochemistry in 1971, and a residency in Internal Medicine. Subsequently, he was a fellow in Metabolism and then a junior faculty member at Washington University Medical School and Barnes Hospital in St. Louis. In 1974, he transferred to Baylor College of Medicine in Houston, where he is presently a Professor in the Departments of Medicine, Biochemistry and Molecular Biology, and Molecular and Cellular Biology. In addition to a prior term as a member of the Board of Directors of the American Association of Clinical Endocrinologists (AACE), Dr. Garber has also served on the boards of other organizations, including the National Board of Directors of the American Diabetes Association, the Southern Section of the American Federation of Clinical Research and the Southern Society for Clinical Investigation. Elected positions include those of President of the Southern Society for Clinical Research, The Southern Society for Clinical Investigation, and the Texas Affiliate of the American Diabetes Association. Dr. Garber chaired the Writing Committee for the AACE/ACE Consensus Statement on Outpatient Guidelines for Glycemic Control (2002) and was the co-chair, as well as the chairman, of the Writing Committee for the Consensus Development Conference on Inpatient Diabetes and Metabolic Control (2003). Dr. Garber is a member of the ACE Diabetes Initiative Advisory Board and chairs task forces on diabetes prevention for ACE and AACE and the Coordination of Specialty Societies Monitoring the Appropriate Use of Pharmacological Agents. He was also the co-chair of the Organizing Committee for the 2005 AACE Annual Meeting in Washington, DC, and co-chair of the 2005 AACE Annual Meeting. Most recently, Dr. Garber co-chaired the AACE/ACE/ADA 2006 Inpatient Diabetes and Control: A Call to Action Consensus Conference and chaired the writing panel which produced the resulting Consensus Statement recommending strategies for improving patient care. Additional current memberships in AACE task forces include the Task Force for Endocrine Educational Services, the Inpatient Diabetes Management Implementation Consensus Conference Task Force to Communicate with JCAHO, the Task Force to Review the Endotext Proposal and the Optimal Diabetes Care Task Force.
|
||